Log in
Enquire now
‌

Perioperative Analgesia for Knee Arthroplasty (PAKA)

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT01560767
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT015607670
Health Conditions in Trial
‌
Knee arthritis
0
Trial Recruitment Size
460
Trial Sponsor
University of Warwick
University of Warwick
0
Clinical Trial Start Date
2010
0
Primary Completion Date
2011
0
Study Completion Date
2011
0
Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Supportive Care0
Intervention Type
Drug0
Interventional Trial Phase
Phase 40
Official Name
Can Periarticular Knee Injection of Multimodal Agents Levobupivicaine, Morphine, Ketorolac and Adrenaline Improve Postoperative Pain and Function Following Primary Total Knee Arthroplasty?0
Last Updated
March 22, 2012
0
Allocation Type
Randomized0
Intervention Model
Factorial Assignment0
Masking Type
Double0
Masked Party
Outcomes Assessor0
Participant0

Other attributes

Intervention Treatment
Femoral Nerve Block0
peri-articular infiltration0
Study summary

Peri-articular knee infiltration with Levobupivicaine 150mg, Morphine 10mg and Ketorolac 30mg reduces postoperative pain following primary total knee replacement compared with the current standard treatment of femoral nerve blockade.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Perioperative Analgesia for Knee Arthroplasty (PAKA)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.